Hear from other medical professionals who treat atopic dermatitis

DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT can be used with or without topical corticosteroids.

Please view entire video for clinical trial efficacy and safety data and for full Important Safety Information.

Providers are paid consultants.

Hear from DUPIXENT patients

Actual patients treated with DUPIXENT. Individual results may vary.

Hear caregivers of DUPIXENT pediatric patients

Download helpful resources about DUPIXENT for uncontrolled moderate-to-severe atopic dermatitis

ADOLESCENTS (AGED 12-17 YEARS)
TREATED WITH DUPIXENT

CHILDREN (AGED 6-11 YEARS)
TREATED WITH DUPIXENT

INFANTS TO PRESCHOOLERS
(AGED 6 MONTHS TO 5 YEARS)
PATIENT PROFILES

DOSING INFORMATION
FOR DUPIXENT
 

Mark your calendars for these future events

American College of Allergy,
Asthma, & Immunology
Annual Scientific Meeting

November 10-14, 2022
Louisville, KY

American Academy of
Allergy, Asthma & Immunology Annual Meeting
 
February 24-27, 2023
San Antonio, TX

DUPIXENT MyWay is a patient support program that can help enable access
to DUPIXENT and offers financial assistance for eligible patients, one-on-one
nursing support, and more.

DUPIXENT MyWay
ENROLLMENT FORMS

FOR DERMATOLOGISTS
English Enrollment Form
Spanish Enrollment Form
FOR ALLERGISTS
English Enrollment Form
Spanish Enrollment Form